SCM
ENVB icon

Sio Capital Management’s Enveric Biosciences ENVB Stock Holding History

Sio Capital Management’s Portfolio ENVB Stock Details ENVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
+180,000
New +$432K 0.04% 55

Other funds holding ENVB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Sio Capital Management's ENVB Position: Q2 2026 in Review

Sio Capital Management opened a new position in Enveric Biosciences (ENVB) in Q2 2026: 180,000 shares worth $248K. The stake represents 0.04% of the portfolio and ranks #55 among its holdings.

25 funds tracked by Wall St. Rank hold ENVB as of Q2 2026.

  • Sio Capital Management held 180,000 shares of Enveric Biosciences worth $248K as of Q2 2026.
  • Enveric Biosciences was a new Sio Capital Management position in Q2 2026.
  • Enveric Biosciences made up 0.04% of Sio Capital Management's portfolio in Q2 2026, its #55 holding.
  • 25 funds tracked by Wall St. Rank held Enveric Biosciences as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.